Core Viewpoint - The company, Gongtong Pharmaceutical, is forecasting a significant net loss for the year 2025, indicating a decline in profitability compared to the previous year [1] Financial Performance - The expected net profit for 2025 is projected to be between -58 million to -75 million, representing a year-on-year decline of 110.21% to 171.83% [1] - The gross profit margin is anticipated to decrease compared to the same period last year [1] Operational Challenges - The decline in profitability is attributed to a slight decrease in market prices for some products [1] - Newly established projects are expected to lead to underutilized capacity, resulting in higher unit product costs [1] - The introduction of new products in 2025 has led to higher initial production costs [1]
共同药业预计2025年净利亏损5800万元至7500万元